Predictive and prognostic analysis of PIK3CA mutation in stage II colon cancer intergroup trial.
Journal of the National Cancer Institute.
Times cited: 32
Predictive and prognostic roles of BRAF mutation in stage III colon cancer: Results from intergroup trial CALGB 89803.
Clinical Cancer Research.
Times cited: 163
The androgen receptor CAG repeat polymorphism and risk of breast cancer in the nurses’ health study.
Times cited: 90